Quitting smoking is a such a difficult challenge for everyone who intends to act on behalf of their health and well-being. The illusion of quitting whenever you wish is not very feasible. But could there be a way to predict which would be the perfect way for you to quit smoking? Scientists might have found the solution. According to the latest studies, there are some specific metabolic reactions that directly influence this fact. And of course, they are different for every human being. Personalized recipe.
42 million Americans smoke at the moment. Maybe right this very moment, someone is lighting a cigar and thinking that this should be the last one. Fortunately, the smoking rate isn’t as high as it was in the 1960s, when it reached its highest peak. Smoking was elegant, it was bohemian, aristocratic, and even a little bit attractive.
The worst news is that the death rates caused by smoking are high. 6 million people die every year because of this unstoppable custom. All over the world, $200 billion dollars are spent for buying cigars. Such a waste of good health and hard worked money. Scientists have struggled for many years to find a real, and optimized solution for this issue.
Metabolism influences every habit that we have. New studies show that thoughts, repetitive actions and self-opinions create physical responses in the body. In fact, it’s a whole culture and the idea has inspired millions of books. So why wouldn’t smoking or quitting it be influenced by every particular body and its metabolic responses? However, it is not the first time that this theory is tried to be put in action. The main difference is that the subjects’ metabolism wasn’t checked and tested before administering the treatments. Furthermore, varenicline wasn’t one of the medications tested.
Researchers from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, the Centre for Addiction and Health at the University of Toronto, Canada, the State University of New York at Buffalo, NY, and The University of Texas MD Anderson Cancer Center in Houston are all involved in this new project.
Firstly, doctors tested subjects’ blood to see whether their metabolic rate during smoking is normal or slow. The relevance was shown in the CYP2A6, the enzyme of the liver that helps metabolize nicotine.
All subjects were then tested for 11 weeks with three types of treatment: the nicotine patch plus a placebo pill, varenicline plus placebo patch, or a placebo patch and pill. The result? 40% of varenicline users haven’t started smoking during the study, in comparison with the 20% of those who used patches. Unfortunately, the quitting got harder after 6 and 12 months after the administration of varenicline.
Scientists are very positive about the results, and they believe that the personalization of the anti-smoking treatment is an idea that could lead to lower mortality rates cause by smoking.
Image Source: The Kerry Gaynor Blog